Ophidion 20logo light
Ophidion 20logo light

Ophidion

Proprietary technology to shuttle drugs across the blood-brain barrier to treat neurodegenerative diseases & brain malignancies following IV administration.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Bethlehem, PA, USA
  • Currency USD
  • Employees 7
  • Incorporation Type C-corp
  • Website ophidionbio.com

Company Summary

Ophidion has a platform technology which uses a Trojan horse strategy to exploit an endogenous receptor-mediated transport system to deliver drugs and biologics into the brain. The technology can be applied to deliver therapeutics to treat various CNS disorders and brain malignancies. We are currently focused on developing a pipeline of gene silencing therapies to treat neurodegenerative diseases (e.g: Alzheimer’s & Huntington’s disease).